HCA Healthcare (HCA) Fundamentals 2026 — P/E 12.7x, Revenue Analysis | SniperIQ
HCA Healthcare (HCA) is a US-listed Healthcare company in Medical - Care Facilities with a market capitalization of $82.7B, trading at
HCA Healthcare (HCA) has a market capitalization of approximately $82.7B, trading at
HCA Healthcare's trailing twelve-month P/E ratio is 12.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
HCA Healthcare runs a net profit margin of 8.9%, a gross margin of 34.9%, and an operating margin of 15.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
HCA Healthcare reported revenue of $75.6B for fiscal year 2025, with net income of $6.8B and earnings per share (EPS) of 28.62. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
HCA Healthcare offers a trailing dividend yield of about 0.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
HCA Healthcare carries a debt-to-equity ratio of -7.91x and a current ratio of 0.83x, with a market beta of 1.13. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For HCA Healthcare (HCA) the key facts are: market cap $82.7B, P/E 12.7x, revenue $75.6B, 52-week range 330-556.52. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Get HCA Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.